Abstract
This article comments on a report that attempts to justify the enrollment of adolescents in HIV prevention trials with a minimal relative standard risk. It argues that ethics committee members research administrators policymakers and other stakeholders should ensure that existing regulations and guidelines are fairly and appropriately applied to all pediatric studies and not just HIV vaccine trials.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
